title: Evaluation of the effects of galbanic acid from Ferula szowitsiana and conferol from F. badrakema, as modulators of multi-drug resistance in clinical isolates of Escherichia coli and Staphylococcus aureus.
abstract: Galbanic acid, a sesquiterpene coumarin from Ferula szowitsiana, and conferol, another sesquiterpene coumarin from F. badrakema, were evaluated for their effects on the reversal of multi-drug resistance in clinical isolates of Staphylococcus aureus and Escherichia coli, respectively. Neither galbanic acid (up to 1000 μg/ml) nor conferol (up to 400 μg/ml) by itself shows any antibacterial activities against tested strains. The minimum inhibitory concentrations (MICs) of ciprofloxacin and tetracycline were determined using macrodilution technique in the presence and absence of sub-inhibitory concentrations of galbanic acid (31.25-1000 μg/ml) or conferol (50-400 μg/ml), however they caused no change in MICs of the antibiotics. Galbanic acid did not show any inhibitory effect on efflux phenomenon of E. coli. This can be related to the outer membrane of gram-negative bacteria which is impermeable to lipophilic compounds or another mechanism rather than efflux responsible for resistance in tested E. coli strains. An inhibitory effect of conferol on the efflux was compared with verapamil as a positive control. Because efflux is the only known mechanism of resistance to ethidium bromide (model efflux substrate) and verapamil reduced MIC of ethidium bromide, efflux mechanism can be considered as one of the resistance mechanisms in tested S. aureus strains. Conferol, however, did not enhance the antibiotic efficacy mediated by inhibiting efflux pumps in bacteria.
authors: Biotechnology Research Center and School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, I.R.Iran.
authors: B S
authors: BS
authors: Fazly Bazzaz
authors: M
authors: M
authors: Iranshahi
authors: M
authors: M
authors: Naderinasab
authors: S
authors: S
authors: Hajian
authors: Z
authors: Z
authors: Sabeti
authors: E
authors: E
authors: Masumi
references: Clin Microbiol Rev. 2006 Apr;19(2):382-402
references: 16614254
references: Int J Antimicrob Agents. 2004 Sep;24(3):241-6
references: 15325427
references: Antimicrob Agents Chemother. 2004 Nov;48(11):4171-6
references: 15504837
references: J Antimicrob Chemother. 2003 Jan;51(1):13-7
references: 12493782
references: Nat Prod Rep. 2005 Aug;22(4):439-51
references: 16047044
references: Planta Med. 2004 Sep;70(9):828-33
references: 15503353
references: Planta Med. 1998 Dec;64(8):711-3
references: 9933989
references: Phytomedicine. 2009 Mar;16(2-3):181-7
references: 18707855
references: J Antimicrob Chemother. 2007 Mar;59(3):425-32
references: 17242033
references: Curr Med Chem. 2001 Dec;8(14):1699-711
references: 11562289
references: J Antimicrob Chemother. 2007 Jun;59(6):1247-60
references: 17145734
references: Antimicrob Agents Chemother. 2003 Oct;47(10):3357-60
references: 14506058
references: J Antimicrob Chemother. 2008 Sep;62(3):504-13
references: 18511413
references: Antimicrob Agents Chemother. 1999 Feb;43(2):335-40
references: 9925528
references: J Antimicrob Chemother. 2001 Jul;48 Suppl 1:5-16
references: 11420333
references: Phytochemistry. 2007 Feb;68(4):554-61
references: 17196626
references: Braz J Microbiol. 2010 Jul;41(3):574-80
references: 24031531
references: Biochimie. 2005 Dec;87(12):1137-47
references: 15951096
references: Biol Pharm Bull. 2007 Sep;30(9):1805-7
references: 17827745
references: Bioorg Med Chem Lett. 2004 Feb 23;14(4):881-5
references: 15012986